Table 1. Changes of biochemistry parameters after all sessions of ALSS treatment.
DGM group | N-DGM group | |
(n = 33) | (n = 51) | |
Total bilirubin | ||
On the day of listing | 28.4±11.8 | 26.6±10.2 |
On the day of transplant* | 19.6±8.6 | 29.2±12.4 |
Alanine aminotransferase | ||
On the day of listing | 132±123 | 148±102 |
On the day of transplant* | 67±46 | 169±97 |
Aspartate aminotransferase | ||
On the day of listing | 195±112 | 202±96 |
On the day of transplant* | 98±76 | 213±105 |
Prothrombin time | ||
On the day of listing | 28.4±11.2 | 30.1±10.6 |
On the day of transplant* | 20.2±7.3 | 31.2±9.8 |
International normalized ratio | ||
On the day of listing | 2.8±0.9 | 2.9±1.1 |
On the day of transplant* | 2.1±0.7 | 3.0±1.2 |
Serum creatinine | ||
On the day of listing | 1.2±0.6 | 1.5±1.0 |
On the day of transplant* | 1.1±0.7 | 1.7±1.1 |
Abbreviations: ALSS, artificial liver support system; DGM, downgraded MELD; MELD, model for end-stage liver disease; N-DGM, non-downgraded MELD;
*: N-DGM group vs. DGM group, P<0.05;